Health – EU supports Austrian biotech with EUR 24 million for antifungal research and innovation

The European Investment Bank (EIB) is lending EUR 24 million to F2G Biotech, a research-intensive company in Austria, focusing on the discovery and development of novel drugs to treat life threatening fungal diseases.

Powered by WPeMatico

Comments

comments